Marinus Pharmaceuticals reported 13.02M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
ALKERMES ALKS:US 223.39M 47.4M
Amgen AMGN:US $ 4677M 451M
Biogen BIIB:US $ 1777.9M 295.8M
Eisai 4523:JP Y 158750M 35913M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Gilead Sciences GILD:US $ 5166M 549M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Intra Cellular Therapies ITCI:US $ 31.84M 8.71M
Marinus Pharmaceuticals MRNS:US 13.02M 11.5M
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Supernus Pharmaceuticals SUPN:US $ 142.06M 11.68M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M
YTE INCY:US $ 696.02M 128.26M